_id

695fb6cfc2e91020a7bd4229

Ticker

0HKF.LSE

Name

Axsome Therapeutics, Inc.

Exchange

LSE

Address

One World Trade Center, New York, NY, United States, 10007

Country

UK

Sector

Industry

Currency

USD

Website

https://www.axsome.com

Description

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT1A agonist indicated for the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea; and Symbravo (MoSEIC meloxicam rizatriptan), or AXS-07, a rapidly absorbed, multi-mechanistic, selective COX-2 inhibitor, and 5-HT1B/1D agonist indicated for the acute treatment of migraine with or without aura. It also develops AXS-05 (dextromethorphan-bupropion), an investigational N-methyl-D-aspartate receptor antagonist, which has completed Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-12 (reboxetine), a highly selective and potent norepinephrine reuptake inhibitor and cortical dopamine modulator, which has completed Phase III trial to treat narcolepsy; AXS-14 (esreboxetine), a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and Solriamfetol, a dopamine and norepinephrine reuptake inhibitor, which is in Phase III trial for treating attention deficit hyperactivity, major depressive, binge eating, and excessive sleepiness associated with shift work disorder. It has a research collaboration agreement with Duke University for evaluating AXS-05 in a Phase 2 clinical trial in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Last Close

170.69

Volume

26

Current Price

170.69

Change

0.39

Last Updated

2026-01-08T13:53:18.982Z

Ipo Date

-

Market Cap

556596121600

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

170992000

Cost Of Revenue

11912000

Gross Profit

159080000

Operating Expenses

205189000

Operating Income

-46109000

Interest Expense

1120000

Pretax Income

-47229000

Net Income

-47229000

Eps

-0.9441673799716048

Dividends Per Share

-

Shares Outstanding

29813200

Income Tax Expense

-

EBITDA

-44382000

Operating Margin

-26.965589033405074

Total Other Income Expense Net

-1120000

Cash

325272000

Short Term Investments

-

Receivables

196507000

Inventories

23774000

Total Current Assets

565342000

Property Plant Equipment

26654000

Total Assets

669250000

Payables

54227000

Short Term Debt

73233000

Long Term Debt

-

Total Liabilities

595523000

Equity

73727000

Bs_currency_symbol

-

Depreciation

2411000

Change In Working Capital

8783000

Cash From Operations

1046000

Capital Expenditures

58000

Cash From Investing

-58000

Cash From Financing

21268000

Net Change In Cash

22256000

Cf_currency_symbol

-

PE

-

PB

115.80872336037001

ROE

-64.05929984944457

ROA

-7.057004109077325

FCF

988000

Fcf Percent

0.005778048095817348

Piotroski FScore

2

Health Score

8

Deep Value Investing Score

3.5

Defensive Investing Score

5

Dividend Investing Score

2.5

Economic Moat Investing Score

4.8

Garp Investing Score

3.5

Growth Investing Score

3.5

Momentum Investing Score

2.5

Net Net Investing Score

3

Quality Investing Score

3

Value Investing Score

2

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

170992000

Quarters > 0 > income Statement > cost Of Revenue

11912000

Quarters > 0 > income Statement > gross Profit

159080000

Quarters > 0 > income Statement > operating Expenses

205189000

Quarters > 0 > income Statement > operating Income

-46109000

Quarters > 0 > income Statement > interest Expense

1120000

Quarters > 0 > income Statement > pretax Income

-47229000

Quarters > 0 > income Statement > net Income

-47229000

Quarters > 0 > income Statement > eps

-0.9441673799716048

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

50021851

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-44382000

Quarters > 0 > income Statement > operating Margin

-26.965589033405074

Quarters > 0 > income Statement > total Other Income Expense Net

-1120000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

325272000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

196507000

Quarters > 0 > balance Sheet > inventories

23774000

Quarters > 0 > balance Sheet > total Current Assets

565342000

Quarters > 0 > balance Sheet > property Plant Equipment

26654000

Quarters > 0 > balance Sheet > total Assets

669250000

Quarters > 0 > balance Sheet > payables

54227000

Quarters > 0 > balance Sheet > short Term Debt

73233000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

595523000

Quarters > 0 > balance Sheet > equity

73727000

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

-47229000

Quarters > 0 > cash Flow > depreciation

2411000

Quarters > 0 > cash Flow > change In Working Capital

8783000

Quarters > 0 > cash Flow > cash From Operations

1046000

Quarters > 0 > cash Flow > capital Expenditures

58000

Quarters > 0 > cash Flow > cash From Investing

-58000

Quarters > 0 > cash Flow > cash From Financing

21268000

Quarters > 0 > cash Flow > net Change In Cash

22256000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

-0.9441673799716048

Quarters > 0 > ratios > PB

115.80872336037001

Quarters > 0 > ratios > ROE

-64.05929984944457

Quarters > 0 > ratios > ROA

-7.057004109077325

Quarters > 0 > ratios > FCF

988000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

0.005778048095817348

Quarters > 0 > health Score

8

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

150042000

Quarters > 1 > income Statement > cost Of Revenue

13448000

Quarters > 1 > income Statement > gross Profit

136594000

Quarters > 1 > income Statement > operating Expenses

173308000

Quarters > 1 > income Statement > operating Income

-36714000

Quarters > 1 > income Statement > interest Expense

1834000

Quarters > 1 > income Statement > pretax Income

-48933000

Quarters > 1 > income Statement > net Income

-47973000

Quarters > 1 > income Statement > eps

-0.9702884187532866

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

49442000

Quarters > 1 > income Statement > income Tax Expense

-960000

Quarters > 1 > income Statement > EBITDA

-42570000

Quarters > 1 > income Statement > operating Margin

-24.469148638381252

Quarters > 1 > income Statement > total Other Income Expense Net

-12219000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

303016000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

198825000

Quarters > 1 > balance Sheet > inventories

18441000

Quarters > 1 > balance Sheet > total Current Assets

536620000

Quarters > 1 > balance Sheet > property Plant Equipment

23139000

Quarters > 1 > balance Sheet > total Assets

639785000

Quarters > 1 > balance Sheet > payables

91628000

Quarters > 1 > balance Sheet > short Term Debt

72351000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

566710000

Quarters > 1 > balance Sheet > equity

73075000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

-47973000

Quarters > 1 > cash Flow > depreciation

1709000

Quarters > 1 > cash Flow > change In Working Capital

-14331000

Quarters > 1 > cash Flow > cash From Operations

-32423000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-13000

Quarters > 1 > cash Flow > cash From Financing

34542000

Quarters > 1 > cash Flow > net Change In Cash

2106000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.9702884187532866

Quarters > 1 > ratios > PB

115.48758097844679

Quarters > 1 > ratios > ROE

-65.64899076291482

Quarters > 1 > ratios > ROA

-7.498300210226873

Quarters > 1 > ratios > FCF

-32423000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.21609282734167767

Quarters > 1 > health Score

9

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

121463000

Quarters > 2 > income Statement > cost Of Revenue

9789000

Quarters > 2 > income Statement > gross Profit

111674000

Quarters > 2 > income Statement > operating Expenses

168656000

Quarters > 2 > income Statement > operating Income

-56982000

Quarters > 2 > income Statement > interest Expense

2431000

Quarters > 2 > income Statement > pretax Income

-59413000

Quarters > 2 > income Statement > net Income

-59413000

Quarters > 2 > income Statement > eps

-1.2157066939454664

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

48871163

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-54849000

Quarters > 2 > income Statement > operating Margin

-46.913051711220696

Quarters > 2 > income Statement > total Other Income Expense Net

-2431000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

300910000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

161398000

Quarters > 2 > balance Sheet > inventories

16319000

Quarters > 2 > balance Sheet > total Current Assets

494634000

Quarters > 2 > balance Sheet > property Plant Equipment

24067000

Quarters > 2 > balance Sheet > total Assets

596671000

Quarters > 2 > balance Sheet > payables

85659000

Quarters > 2 > balance Sheet > short Term Debt

2270000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

543466000

Quarters > 2 > balance Sheet > equity

53205000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

-59413000

Quarters > 2 > cash Flow > depreciation

1721000

Quarters > 2 > cash Flow > change In Working Capital

-10149000

Quarters > 2 > cash Flow > cash From Operations

-43375000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-338000

Quarters > 2 > cash Flow > cash From Financing

29270000

Quarters > 2 > cash Flow > net Change In Cash

-14443000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-1.2157066939454664

Quarters > 2 > ratios > PB

156.7863699364721

Quarters > 2 > ratios > ROE

-111.66807630861761

Quarters > 2 > ratios > ROA

-9.957413717107084

Quarters > 2 > ratios > FCF

-43375000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.3571046326864971

Quarters > 2 > health Score

9

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

118766000

Quarters > 3 > income Statement > cost Of Revenue

10514000

Quarters > 3 > income Statement > gross Profit

108252000

Quarters > 3 > income Statement > operating Expenses

180869000

Quarters > 3 > income Statement > operating Income

-72617000

Quarters > 3 > income Statement > interest Expense

2210000

Quarters > 3 > income Statement > pretax Income

-74827000

Quarters > 3 > income Statement > net Income

-74912000

Quarters > 3 > income Statement > eps

-1.5432439250169518

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

48541905

Quarters > 3 > income Statement > income Tax Expense

85000

Quarters > 3 > income Statement > EBITDA

-70544000

Quarters > 3 > income Statement > operating Margin

-61.142919690820605

Quarters > 3 > income Statement > total Other Income Expense Net

-2210000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

315353000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

142001000

Quarters > 3 > balance Sheet > inventories

15732000

Quarters > 3 > balance Sheet > total Current Assets

485064000

Quarters > 3 > balance Sheet > property Plant Equipment

5967000

Quarters > 3 > balance Sheet > total Assets

568498000

Quarters > 3 > balance Sheet > payables

71997000

Quarters > 3 > balance Sheet > short Term Debt

3256000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

511483000

Quarters > 3 > balance Sheet > equity

57015000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

-74912000

Quarters > 3 > cash Flow > depreciation

2073000

Quarters > 3 > cash Flow > change In Working Capital

12799000

Quarters > 3 > cash Flow > cash From Operations

-26202000

Quarters > 3 > cash Flow > capital Expenditures

30000

Quarters > 3 > cash Flow > cash From Investing

-30000

Quarters > 3 > cash Flow > cash From Financing

14244000

Quarters > 3 > cash Flow > net Change In Cash

-11988000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-1.5432439250169518

Quarters > 3 > ratios > PB

145.32347214680348

Quarters > 3 > ratios > ROE

-131.38998509164256

Quarters > 3 > ratios > ROA

-13.177179163339185

Quarters > 3 > ratios > FCF

-26232000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.22087129313103077

Quarters > 3 > health Score

9

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

385693000

Annuals > 0 > income Statement > cost Of Revenue

33303000

Annuals > 0 > income Statement > gross Profit

352390000

Annuals > 0 > income Statement > operating Expenses

632952000

Annuals > 0 > income Statement > operating Income

-280562000

Annuals > 0 > income Statement > interest Expense

6569000

Annuals > 0 > income Statement > pretax Income

-287131000

Annuals > 0 > income Statement > net Income

-287216000

Annuals > 0 > income Statement > eps

-5.994406645239387

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

47914000

Annuals > 0 > income Statement > income Tax Expense

85000

Annuals > 0 > income Statement > EBITDA

-272604000

Annuals > 0 > income Statement > operating Margin

-72.74231059417724

Annuals > 0 > income Statement > total Other Income Expense Net

-6569000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

315353000

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

142001000

Annuals > 0 > balance Sheet > inventories

15732000

Annuals > 0 > balance Sheet > total Current Assets

485064000

Annuals > 0 > balance Sheet > property Plant Equipment

5967000

Annuals > 0 > balance Sheet > total Assets

568498000

Annuals > 0 > balance Sheet > payables

71997000

Annuals > 0 > balance Sheet > short Term Debt

3256000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

511483000

Annuals > 0 > balance Sheet > equity

57015000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

-287216000

Annuals > 0 > cash Flow > depreciation

7958000

Annuals > 0 > cash Flow > change In Working Capital

33900000

Annuals > 0 > cash Flow > cash From Operations

-128410000

Annuals > 0 > cash Flow > capital Expenditures

270000

Annuals > 0 > cash Flow > cash From Investing

-270000

Annuals > 0 > cash Flow > cash From Financing

57840000

Annuals > 0 > cash Flow > net Change In Cash

-70840000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

-5.994406645239387

Annuals > 0 > ratios > PB

143.44366675436288

Annuals > 0 > ratios > ROE

-503.7551521529422

Annuals > 0 > ratios > ROA

-50.52190157221309

Annuals > 0 > ratios > FCF

-128680000

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-0.3336332264261991

Annuals > 0 > health Score

8

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

270600000

Annuals > 1 > income Statement > cost Of Revenue

26065000

Annuals > 1 > income Statement > gross Profit

244535000

Annuals > 1 > income Statement > operating Expenses

476360000

Annuals > 1 > income Statement > operating Income

-231825000

Annuals > 1 > income Statement > interest Expense

6453000

Annuals > 1 > income Statement > pretax Income

-238278000

Annuals > 1 > income Statement > net Income

-239238000

Annuals > 1 > income Statement > eps

-5.266634749002383

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

45425212

Annuals > 1 > income Statement > income Tax Expense

960000

Annuals > 1 > income Statement > EBITDA

-224991000

Annuals > 1 > income Statement > operating Margin

-85.67073170731707

Annuals > 1 > income Statement > total Other Income Expense Net

-6453000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

386193000

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

94820000

Annuals > 1 > balance Sheet > inventories

15135000

Annuals > 1 > balance Sheet > total Current Assets

504263000

Annuals > 1 > balance Sheet > property Plant Equipment

7618000

Annuals > 1 > balance Sheet > total Assets

588236000

Annuals > 1 > balance Sheet > payables

40679000

Annuals > 1 > balance Sheet > short Term Debt

1267000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

397259000

Annuals > 1 > balance Sheet > equity

190977000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

-239238000

Annuals > 1 > cash Flow > depreciation

6834000

Annuals > 1 > cash Flow > change In Working Capital

-28392000

Annuals > 1 > cash Flow > cash From Operations

-145080000

Annuals > 1 > cash Flow > capital Expenditures

582000

Annuals > 1 > cash Flow > cash From Investing

-582000

Annuals > 1 > cash Flow > cash From Financing

331013000

Annuals > 1 > cash Flow > net Change In Cash

185351000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-5.266634749002383

Annuals > 1 > ratios > PB

40.599807496609536

Annuals > 1 > ratios > ROE

-125.27058232143138

Annuals > 1 > ratios > ROA

-40.67041119550657

Annuals > 1 > ratios > FCF

-145662000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-0.5382926829268293

Annuals > 1 > health Score

12

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

50037000

Annuals > 2 > income Statement > cost Of Revenue

5198000

Annuals > 2 > income Statement > gross Profit

44839000

Annuals > 2 > income Statement > operating Expenses

224638000

Annuals > 2 > income Statement > operating Income

-179799000

Annuals > 2 > income Statement > interest Expense

7335000

Annuals > 2 > income Statement > pretax Income

-187134000

Annuals > 2 > income Statement > net Income

-187134000

Annuals > 2 > income Statement > eps

-4.6028697257308595

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

40655941

Annuals > 2 > income Statement > income Tax Expense

-

Annuals > 2 > income Statement > EBITDA

-175397000

Annuals > 2 > income Statement > operating Margin

-359.33209425025484

Annuals > 2 > income Statement > total Other Income Expense Net

-7335000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

200842000

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

37699000

Annuals > 2 > balance Sheet > inventories

4320000

Annuals > 2 > balance Sheet > total Current Assets

245642000

Annuals > 2 > balance Sheet > property Plant Equipment

1142000

Annuals > 2 > balance Sheet > total Assets

331476000

Annuals > 2 > balance Sheet > payables

38605000

Annuals > 2 > balance Sheet > short Term Debt

425000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

221920000

Annuals > 2 > balance Sheet > equity

109556000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

-187134000

Annuals > 2 > cash Flow > depreciation

4402000

Annuals > 2 > cash Flow > change In Working Capital

23670000

Annuals > 2 > cash Flow > cash From Operations

-116511000

Annuals > 2 > cash Flow > capital Expenditures

702000

Annuals > 2 > cash Flow > cash From Investing

-53702000

Annuals > 2 > cash Flow > cash From Financing

284582000

Annuals > 2 > cash Flow > net Change In Cash

114369000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-4.6028697257308595

Annuals > 2 > ratios > PB

63.342606240552776

Annuals > 2 > ratios > ROE

-170.8112745992917

Annuals > 2 > ratios > ROA

-56.4547659559063

Annuals > 2 > ratios > FCF

-117213000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-2.342526530367528

Annuals > 2 > health Score

12

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

-

Annuals > 3 > income Statement > cost Of Revenue

-

Annuals > 3 > income Statement > gross Profit

-

Annuals > 3 > income Statement > operating Expenses

124707000

Annuals > 3 > income Statement > operating Income

-124707000

Annuals > 3 > income Statement > interest Expense

5696000

Annuals > 3 > income Statement > pretax Income

-130403000

Annuals > 3 > income Statement > net Income

-130403000

Annuals > 3 > income Statement > eps

-3.466450199275098

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

37618599

Annuals > 3 > income Statement > income Tax Expense

-

Annuals > 3 > income Statement > EBITDA

-124631000

Annuals > 3 > income Statement > operating Margin

-

Annuals > 3 > income Statement > total Other Income Expense Net

-5696000

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

86472854

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

-

Annuals > 3 > balance Sheet > inventories

-

Annuals > 3 > balance Sheet > total Current Assets

86518140

Annuals > 3 > balance Sheet > property Plant Equipment

944008

Annuals > 3 > balance Sheet > total Assets

87785058

Annuals > 3 > balance Sheet > payables

13149329

Annuals > 3 > balance Sheet > short Term Debt

620675

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

72154706

Annuals > 3 > balance Sheet > equity

15630352

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

-130403000

Annuals > 3 > cash Flow > depreciation

76000

Annuals > 3 > cash Flow > change In Working Capital

324000

Annuals > 3 > cash Flow > cash From Operations

-108226000

Annuals > 3 > cash Flow > capital Expenditures

308000

Annuals > 3 > cash Flow > cash From Investing

-308000

Annuals > 3 > cash Flow > cash From Financing

11130000

Annuals > 3 > cash Flow > net Change In Cash

-97404000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-3.466450199275098

Annuals > 3 > ratios > PB

410.8108802226591

Annuals > 3 > ratios > ROE

-834.2934311396186

Annuals > 3 > ratios > ROA

-148.54805928361975

Annuals > 3 > ratios > FCF

-108534000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-

Annuals > 3 > health Score

16

Valuation > metrics > PE

-0.9441673799716048

Valuation > metrics > PB

115.80872336037001

Valuation > final Score

20

Valuation > verdict

3760.3% Overvalued

Profitability > metrics > ROE

-64.05929984944457

Profitability > metrics > ROA

-8.354058251465485

Profitability > metrics > Net Margin

-0.2762059043697951

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

8.077407191395283

Risk > metrics > Interest Coverage

-41.16875

Risk > final Score

-159

Risk > verdict

High

Liquidity > metrics > Current Ratio

4.435446414561431

Liquidity > metrics > Quick Ratio

4.248925152989173

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-74

Prev Risks > 1

-88

Prev Risks > 2

-125

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-23T20:09:36.947Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-02-17

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

BeforeMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-0.81

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-